Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.190
0.00 (0.00%)
At close: Dec 20, 2024, 4:00 PM
1.230
+0.040 (3.37%)
After-hours: Dec 20, 2024, 7:11 PM EST

Atai Life Sciences Revenue

Atai Life Sciences had revenue of $40.00K in the quarter ending September 30, 2024, a decrease of -54.02%. This brings the company's revenue in the last twelve months to $331.00K, down -0.90% year-over-year. In the year 2023, Atai Life Sciences had annual revenue of $314.00K with 34.76% growth.

Revenue (ttm)
$331.00K
Revenue Growth
-0.90%
P/S Ratio
n/a
Revenue / Employee
$3,988
Employees
83
Market Cap
199.68M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023314.00K81.00K34.76%
Dec 31, 2022233.00K-20.14M-98.86%
Dec 31, 202120.38M--
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 331.52M
MacroGenics 141.33M
ADC Therapeutics 70.72M
Biodesix 65.56M
SOPHiA GENETICS 64.49M
Verastem 10.00M
Akso Health Group 2.41M
Inhibrx Biosciences 1.57M
Revenue Rankings